Citaat | Rechtbank Den Haag 27 juli 2016

Onder 2.6. Rechtbank Den Haag 27 juli 2016

Een alinea uit Rechtbank Den Haag 27 juli 2016, ECLI:NL:RBDHA:2016:8596.

[0023] An injection device for a single application according to the present invention preferably contains a dose of the active substance methotrexate of 5 mg to 40 mg. It is especially preferred that an injection device for a single application according to the present invention contains a dose of 5.0, 7.5, 10.0, 12.5, 15.0, 17.5, 20.0, 22.5, 25.0, 27.5, 30.0, 32.5, 35.0, 37.5 or 40.0 mg. The volume of the liquid necessary to provide the desired dose, which has to be contained in the injection device for a single application, depends on the concentration of the active substance solution and is obvious to the person skilled in the art. Thus, in order to provide a dose of active substance of 30.0 mg at a methotrexate concentration according to the present invention in the pharmaceutically acceptable solvent of 50 mg/ml, an injection device for a single application would have to contain a liquid volume of 0.6 ml.

Zelf controleren

Voor dit citaat hoeft niemand Bron op zijn woord te geloven. Het document dat rechtspraak.nl publiceerde, staat op https://bron.page/api/v1/blobs/8f842dbfd37efdf2d5055bb9e5cc85a38df4f8e931abef458724fcb63e78d19e. Wie het ophaalt en de SHA-256 ervan berekent, krijgt 8f842dbfd37efdf2d5055bb9e5cc85a38df4f8e931abef458724fcb63e78d19e, en de alinea staat in dat document op bytes 34748 tot 35685.